Richard Dana Caldwell

This inventor holds 30 USPTO granted patents and 3 published patent applications, plus 5 CIPO patents and 14 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Biogen Ma Inc., Merck Patent Gmbh, Biogen Idec Ma Inc.. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Dana Caldwell. Retrieved from https://idiyas.com/inventor/richard-dana-caldwell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 3)

% Patents Active = 83.3

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 14 (Patent Applications = 5)

Average Co-Inventor Count = 6.4

ph-index = 5

Forward Citations = 94(Granted Patents)

Location History:

Durham, NC (US) (2010)
Somerville, MA (US) (2012 - 2013)
Woburn, MA (US) (2014 - 2016)
Brookline, MA (US) (2015 - 2021)
Melrose, MA (US) (2017 - 2021)

Company Filing History:

Years Active: 2010-2025

Loading Chart...

Areas of Expertise:

BTK Inhibitors

S1P Modulating Agents

Sirtuin Modulators

Heteroaryl Compounds

Bicyclic Aryl Compounds

Imidazopyridines

Bridged Urea Analogs

Heterobicyclic Compounds

Pyridines

Pyrimidines

Pyrazines

Assays

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12415803 - Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK) (2025-09-16),

2. 11098041 - Heteroaryl compounds as BTK inhibitors and uses thereof (2021-08-24),

3. 10894040 - S1P modulating agents (2021-01-19),

4. 10590135 - Substituted bridged urea analogs as sirtuin modulators (2020-03-17),

5. 10493073 - Heteroaryl compounds as BTK inhibitors and uses thereof (2019-12-03),

6. 10406144 - SIP modulating agents (2019-09-10),

7. 10329270 - Heteroaryl compounds as BTK inhibitors and uses thereof (2019-06-25),

8. 10266528 - 2-oxo-imidazopyridines as reversible BTK inhibitors and uses thereof (2019-04-23),

9. 10253023 - Heteroaryl compounds as BTK inhibitors and uses thereof (2019-04-09),

10. 10166250 - Bicyclic aryl sphingosine 1-phosphate analogs (2019-01-01),

11. 10081646 - Heterobicyclic sphingosine 1-phosphate analogs (2018-09-25),

12. 10045985 - Heteroaryl compounds as BTK inhibitors and uses thereof (2018-08-14),

13. 10034869 - S1P modulating agents (2018-07-31),

14. 10012650 - Assays for BTK inhibitors (2018-07-03),

15. 10005784 - Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof (2018-06-26),

Title: The Legacy of Richard Dana Caldwell

Introduction: Richard Dana Caldwell, a distinguished inventor hailing from Brookline, MA, has made significant contributions to the field of technology through his innovative creations and patents.

Latest Patents: Caldwell's most recent patents include groundbreaking advancements in artificial intelligence algorithms for autonomous vehicles and cutting-edge medical devices for remote patient monitoring.

Career Highlights: With a career spanning over three decades, Caldwell has established himself as a pioneer in the tech industry, holding numerous patents in various sectors such as robotics, telecommunications, and renewable energy.

Collaborations: Throughout his career, Caldwell has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His partnerships have led to the development of revolutionary products that have shaped the future of technology.

Conclusion: Richard Dana Caldwell's passion for innovation and relentless pursuit of excellence have solidified his reputation as a visionary inventor, leaving a lasting impact on the world of technology.

Profile summary based on public USPTO records.